To further test the expression patterns of HNRNPL and HNRNPA2B1 in PC, we employed one Oncomine dataset and found that HNRNPL was statistically higher in pancreatic cancer as opposed to normal tissues, while HNRNPA2B1 was not significantly upregulated in Segara Pancreas (Figure 1(d)). The gene discussed is HNRNPL; the disease is pachyonychia congenita.